135 related articles for article (PubMed ID: 33989666)
1. The regulation of protein acetylation influences the redox homeostasis to protect the heart.
Zúñiga-Muñoz A; García-Niño WR; Carbó R; Navarrete-López LÁ; Buelna-Chontal M
Life Sci; 2021 Jul; 277():119599. PubMed ID: 33989666
[TBL] [Abstract][Full Text] [Related]
2. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Li P; Ge J; Li H
Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
[TBL] [Abstract][Full Text] [Related]
3. Chromatin modifications remodel cardiac gene expression.
Mathiyalagan P; Keating ST; Du XJ; El-Osta A
Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
5. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
6. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
[TBL] [Abstract][Full Text] [Related]
7. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
8. Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.
Yang M; Zhang Y; Ren J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165836. PubMed ID: 32413386
[TBL] [Abstract][Full Text] [Related]
9. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
Habibian J; Ferguson BS
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
[TBL] [Abstract][Full Text] [Related]
10. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
Harrison IF; Smith AD; Dexter DT
Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
Ciesielski O; Biesiekierska M; Balcerczyk A
Molecules; 2020 May; 25(10):. PubMed ID: 32429384
[TBL] [Abstract][Full Text] [Related]
12. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
14. A translational perspective on histone acetylation modulators in psychiatric disorders.
Ganguly S; Seth S
Psychopharmacology (Berl); 2018 Jul; 235(7):1867-1873. PubMed ID: 29915963
[TBL] [Abstract][Full Text] [Related]
15. The biology and therapeutic implications of HDACs in the heart.
McKinsey TA
Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
[TBL] [Abstract][Full Text] [Related]
16. The acetyl code in rheumatoid arthritis and other rheumatic diseases.
Angiolilli C; Baeten DL; Radstake TR; Reedquist KA
Epigenomics; 2017 Apr; 9(4):447-461. PubMed ID: 28102705
[TBL] [Abstract][Full Text] [Related]
17. Histone acetylation in gene regulation.
Verdone L; Agricola E; Caserta M; Di Mauro E
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
[TBL] [Abstract][Full Text] [Related]
18. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.
Rafehi H; Karagiannis TC; El-Osta A
Curr Top Med Chem; 2017; 17(14):1611-1622. PubMed ID: 27823568
[TBL] [Abstract][Full Text] [Related]
20. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.
Langley B; Gensert JM; Beal MF; Ratan RR
Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):41-50. PubMed ID: 15723612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
